Standard Review

Standard Review is a regulatory evaluation process within the New Drug Application framework, distinguished by a standard timeframe and comprehensive assessment of safety, efficacy, and quality data to determine the approval of a novel therapeutic agent.

68

Publications

2.9K

Citations

216

Authors

142

Institutions

Publications per year

2017–2026

11

Authors

216

  1. RF
    Richard F. Spaide

    Vitreous Retina Macula Consultants of New York, United States

    4 publications · 94 citations

    4

    h-index

  2. HÖ
    Hakan Özdemir

    Istanbul Retina Institute (Turkey), Türkiye

    2 publications · 42 citations

    2

    h-index

  3. MK
    Murat Karaçorlu

    Istanbul Retina Institute (Turkey), Türkiye

    2 publications · 42 citations

    2

    h-index

  4. SK
    Serra Karaçorlu

    Istanbul Retina Institute (Turkey), Türkiye

    2 publications · 42 citations

    2

    h-index

  5. JL
    Joel Lexchin

    York University, Canada

    2 publications · 75 citations

    2

    h-index

1–5 of 216

Venues

  1. Retina

    34 publications · 1.7K citations

    20

    h-index

  2. JAMA

    2 publications · 315 citations

    2

    h-index

  3. Environmental Science Nano

    1 publications · 35 citations

    1

    h-index

  4. British Journal of Clinical Pharmacology

    BJCP · 1 publications · 51 citations

    1

    h-index

  5. The International Journal of Life Cycle Assessment

    LCA · 1 publications · 18 citations

    1

    h-index

1–5